Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice

被引:23
作者
Akhtar, M [1 ]
Pillai, KK [1 ]
Vohora, D [1 ]
机构
[1] Hamdard Univ, Fac Pharm, Dept Pharmacol, New Delhi 110062, India
关键词
D O I
10.1111/j.1742-7843.2005.pto_140.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was designed i) to investigate the role of histamine H-3-receptor ligands on mouse modified forced swimming test, a method that distinguishes the catecholaminergic behaviour with that of serotonergic compounds and ii) to evaluate the role of free radicals in mediation of such effects. Swiss strain albino mice were treated with different doses of histamine H-3-receptor antagonist thioperamide (3.75, 7.5 and 15 mg/kg intraperitoneally) and agonist (R)-alpha-methylhistamine (5 mu g intracerebroventricularly). The climbing, swimming and immobility times were recorded for 6 min. Immediately after modified forced swimming test, the animals were sacrificed and parameters of oxidative stress were assessed in the brain by measuring the thiobarbituric acid reactive substance (TBARS), glutathione (GSH) and catalase levels. Thioperamide (7.5 and 15 mg/kg intraperitoneally) dose-dependently decreased immobility time and increased swimming time but not climbing time. The behaviour of mice treated with (R)-alpha-methylhistamine was similar to that of control mice. A significant reduction in GSH and an increase in catalase levels were observed in brains of mice exposed to modified forced swimming test. Thioperamide pretreatment dose-dependently reversed such an alteration in oxidative stress parameters. (R)-alpha-methylhistamine caused a reversal of altered catalase but not GSH levels. Thioperamide shows antidepressant effects in the modified forced swimming test and causes a reversal of the test-induced oxidative stress indicating its antioxidant potential. The antidepressant effect of thioperamide appears to be mediated via serotonergic and/or antioxidant mechanisms.
引用
收藏
页码:218 / 221
页数:4
相关论文
共 20 条
[1]   BLOOD GLUTATHIONE LEVEL IN MENTAL DISEASE BEFORE AND AFTER TREATMENT [J].
ALTSCHULE, MD ;
SIEGEL, EP ;
HENNEMAN, DH .
AMA ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1952, 67 (01) :64-68
[2]  
Claiborne A., 1985, CRC HDB METHODS OXYG, P283
[3]   Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test [J].
Cryan, JF ;
Page, ME ;
Lucki, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (03) :197-205
[4]  
Cryan JF, 2000, J PHARMACOL EXP THER, V295, P1120
[5]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[6]   Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury [J].
Ho, YS ;
Xiong, Y ;
Ma, WC ;
Spector, A ;
Ho, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :32804-32812
[7]   Decreased histamine H1 receptor binding in the brain of depressed patients [J].
Kano, M ;
Fukudo, S ;
Tashiro, A ;
Utsumi, A ;
Tamura, D ;
Itoh, M ;
Iwata, R ;
Tashiro, M ;
Mochizuki, H ;
Funaki, Y ;
Kato, M ;
Hongo, M ;
Yanai, K .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (03) :803-810
[8]   ASSAY FOR LIPID PEROXIDES IN ANIMAL-TISSUES BY THIOBARBITURIC ACID REACTION [J].
OHKAWA, H ;
OHISHI, N ;
YAGI, K .
ANALYTICAL BIOCHEMISTRY, 1979, 95 (02) :351-358
[9]  
ONODERA K, 1991, METHOD FIND EXP CLIN, V13, P397
[10]   NEUROPHARMACOLOGY OF THE HISTAMINERGIC NEURON SYSTEM IN THE BRAIN AND ITS RELATIONSHIP WITH BEHAVIORAL-DISORDERS [J].
ONODERA, K ;
YAMATODANI, A ;
WATANABE, T ;
WADA, H .
PROGRESS IN NEUROBIOLOGY, 1994, 42 (06) :685-702